---
layout: post
title: HNRNPM
date: 2024-12-08 23:57 CST
description: HNRNPM description
tags: [cooccuring-genes]
categories: shortest
pretty_table: true
citation: true
related_posts: true
---



| [NCBI ID](https://www.ncbi.nlm.nih.gov/gene/4670) | NCBI symbol | ENSEMBL ID | Chromosome location |
| :-------- | :------- | :-------- | :------- |
| 4670  | HNRNPM | ENSG00000099783 | 19p13.2 |



The gene length is 668.0 base pairs (0.78% of all genes). The mature length is 668.0 base pairs, and the primary transcript length is 668.0 base pairs.


The gene HNRNPM, with NCBI ID 4670, has been the subject of [39 publications](https://pubmed.ncbi.nlm.nih.gov/?term=%22HNRNPM%22) according to [Pubtator](https://academic.oup.com/nar/article/47/W1/W587/5494727), with the earliest publication in 1993 and the middle 50% of publications occurring between 2010 and 2019. Note that the publication count in the hyperlink may be different since the count is from Pubtator.


The top five publications mentioning HNRNPM, ranked by their relative citation ratio (RCR), which measures the scientific influence of each paper by field- and time-adjusting the citations it has received and benchmarking to the median for NIH publications, are as follows. The most influential publication is "[Cell type-restricted activity of hnRNPM promotes breast cancer metastasis via regulating alternative splicing.](https://pubmed.ncbi.nlm.nih.gov/24840202)" (2014) with an RCR of 4.81. Another notable study is "[<i>CircURI1</i> interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer.](https://pubmed.ncbi.nlm.nih.gov/34385309)" (2021), which has an RCR of 4.39. Additionally, "[DAR, a new RhD variant involving exons 4, 5, and 7, often in linkage with ceAR, a new Rhce variant frequently found in African blacks.](https://pubmed.ncbi.nlm.nih.gov/10590079)" (1999) has an RCR of 2.71. The publication "[Cancer-Associated MORC2-Mutant M276I Regulates an hnRNPM-Mediated CD44 Splicing Switch to Promote Invasion and Metastasis in Triple-Negative Breast Cancer.](https://pubmed.ncbi.nlm.nih.gov/30093560)" (2018) has an RCR of 2.52. Lastly, "[Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.](https://pubmed.ncbi.nlm.nih.gov/35158098)" (2022) has an RCR of 2.02. The citation counts are sourced from [iCite](https://icite.od.nih.gov).





The top transcription factors (TFs) identified from the GTRD database, based on the number of CHIP-seq experiments, include [TRPS1](https://www.ncbi.nlm.nih.gov/gene/7227), [MBD4](https://www.ncbi.nlm.nih.gov/gene/8930), [NR3C1](https://www.ncbi.nlm.nih.gov/gene/2908), [SMARCA4](https://www.ncbi.nlm.nih.gov/gene/6597), and [MYCN](https://www.ncbi.nlm.nih.gov/gene/4613), each shown to be regulating in 5 experiments.








The mouse ortholog gene 76936 and its human ortholog gene 4670 are associated with the phenotype of preweaning lethality with complete penetrance, observed in both sexes.


The analyzed protein sequence has a GRAVY value of -0.342 (53.15th percentile), indicating a hydrophilic nature. It exhibits a charge of 6.48 at pH 7.0 (72.56th percentile) and a median structural flexibility of 1.007 (69.98th percentile). The protein's secondary structure is predicted to be 36.6% helix (83.45th percentile), 22.7% sheet (4.53rd percentile), and 35.1% turn (89.47th percentile). The instability index is 39.7 (21.27th percentile), with an isoelectric point of 8.84 (75.01st percentile). The protein has a length of 730 amino acids (77.12th percentile) and a molecular weight of 77514.86 Da (74.96th percentile). For more details on the sequence analysis, refer to the [BioPython documentation](https://biopython.org/docs/1.75/api/Bio.SeqUtils.ProtParam.html).



| Checks    | Answer |
| :-------- | :------- |
| Sentiment  | neutral   |
| Ethical concerns | no     |
| Coherence    | yes    |